DocMorris AG (0RRB) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Docmorris Ltd.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.233 -- 00:00:05.361 Good morning, everyone, and welcome to our Q126 trading update. 00:00:05.361 -- 00:00:11.891 I'm Walter Hess, the CEO, and I'm joined today by our CFO, Danielle Wüst. 00:00:11.891 -- 00:00:17.841 In line with what we announced at the Fulia conference, we will provide transparent 00:00:17.841 -- 00:00:22.868 quarterly insights into our path to EBITDA breakeven, 00:00:22.868 -- 00:00:27.055 which is why we are hosting today's call. 00:00:27.055 -- 00:00:32.144 Just a few weeks ago, During our full year 25 results, we 00:00:32.144 -- 00:00:37.851 outlined our strategic evolution from an online pharmacy player 00:00:37.851 -- 00:00:42.096 to the leading digital and AI health platform, 00:00:42.096 -- 00:00:47.042 the engine for our profitable expansion at scale. 00:00:47.042 -- 00:00:53.347 Today, we will show you the facts that validate our successful development. 00:00:53.409 -- 00:00:58.553 Let's move straight to the Q1 highlights on the next slide. 00:00:58.553 -- 00:01:03.976 to demonstrate how well this engine is now accelerating. 00:01:05.459 -- 00:01:10.404 Overall, we achieved a strong revenue growth of 10.7% 00:01:10.404 -- 00:01:12.986 year over year. 00:01:12.986 -- 00:01:18.770 Our RX business showed outstanding momentum with a 30.4% 00:01:18.912 -- 00:01:25.058 growth year over year, alongside a strong 7.6% sequential 00:01:25.058 -- 00:01:28.726 growth compared to the previous quarter. 00:01:28.726 -- 00:01:34.655 The growth was fueled by accelerating month over month with a remarkable 00:01:34.655 -- 00:01:39.979 uptick in March, which also continues in April. 00:01:40.022 -- 00:01:46.151 Our high-margin digital services business continues to scale rapidly, 00:01:46.151 -- 00:01:51.419 achieving an impressive 63.1% grow...